Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

vTv Therapeutics (VTVT) Return on Invested Capital (2017 - 2024)

vTv Therapeutics (VTVT) has disclosed Return on Invested Capital for 7 consecutive years, with 1.61% as the latest value for Q4 2024.

  • Quarterly Return on Invested Capital changed N/A to 1.61% in Q4 2024 from the year-ago period, while the trailing twelve-month figure was 1.61% through Dec 2024, changed N/A year-over-year, with the annual reading at 3.89% for FY2024, N/A changed from the prior year.
  • Return on Invested Capital hit 1.61% in Q4 2024 for vTv Therapeutics, down from 1.26% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 2.83% in Q2 2022 to a low of 36.41% in Q1 2024.
  • Historically, Return on Invested Capital has averaged 2.19% across 4 years, with a median of 0.26% in 2021.
  • Biggest five-year swings in Return on Invested Capital: decreased -28bps in 2021 and later surged 264bps in 2022.
  • Year by year, Return on Invested Capital stood at 0.42% in 2020, then surged by 231bps to 1.39% in 2021, then rose by 19bps to 1.66% in 2022, then tumbled by -197bps to 1.61% in 2024.
  • Business Quant data shows Return on Invested Capital for VTVT at 1.61% in Q4 2024, 1.26% in Q3 2024, and 0.99% in Q2 2024.